Fertility treatment involves many decisions, big and small. At Genea, we are using artificial intelligence and a purpose-built data platform to make those decisions sharper and more personalised than ever before.
Genea specialists have always tailored treatment to the individual by drawing on clinical experience, patient history, and the latest research. What's changed is the depth of data behind those decisions. With over 40 years of Genea-specific outcomes now accessible in real time, every recommendation is backed by more personalised evidence than ever previously possible.
Australia's first AI-powered patient insight tool
In partnership with Cercle AI, Genea is the first fertility provider in Australia to introduce an AI-powered patient insight tool built on our real-world data.
Cercle AI analysed over one billion global data points, together with Genea data, to deliver a tool that generates personalised insights across multiple cycles, including egg retrieval expectations and treatment pathway considerations, to help patients make more informed decisions with their specialist. Rather than relying on general population averages, your specialist can more easily access data that relates specifically to someone with your profile, history, and circumstances.
This tool doesn't make decisions. It helps inform them. Your specialist reviews the patient insights alongside everything else they know about you, and together you decide on the path forward.
What this means for you:
- Insights built around your profile - based on data from patients with similar characteristics to you
- Faster answers - AI surfaces evidence in real time, so decisions can be made with less delay
- Consistent, standardised care - insights from across the entire Genea network mean every patient benefits from collective outcomes, regardless of which clinic they attend
- Human expertise, enhanced by data - your specialist still makes every decision together with you, but with more evidence behind them than ever before